Causes of deferring chemotherapy administration to ambulatory pediatric patients
Keywords:
Deferreing, Chemotherapy, Ambulatory, pediatric patientsAbstract
Introduction: Chemotherapy has precise indications; deferring it might influence the treatment outcomes. Some causes are originated for clinical situations of patients and others for medical or administrative reasons.
Objective: To identify the main causes that deferring chemothe- rapy administration originates in pediatric patients with cancer.
Methodology: Observational and prospective study included 200 patients from 11 months to 16 years and 11 months old with hemato-onchology disorders. Causes of deferring therapy were researched throughout a check list and direct observation during 3 months. The researched variables were: not showing up to the treatment visit, medical causes, administrative reasons, and clinical causes related to patients. Statistical analysis was done with measures of central tendency.
Results: Causes of deferring chemotherapy administration were: 13.5% due to not showing up to the treatment visit with 10.5%, followed by 1.5% traumatic lumbar puncture, and 1% due to neutropenia.
Discussion: The motive of not showing up in 5.5% was not obtained. Deferring might influence the treatment outcome because the lack of administration might favor the beginning of drug resistant colonies to chemotherapy, having as a consequence losing control of the disease.
Conclusions: Some strategies should be implemented with the help of a multidisciplinary team to reach pa- tients and remind their parents their appointment, as well as let them know about the importance of com- pliance of treatment in booked da- tes.
References
INEGI. México Hoy 2005,México, 2005.
Secretaría de Salud. Principales causas de mortalidad general 2002 [Internet]. Disponible en: www.salud.gob.mx
Cuevas-Urióstwegui ML, Villasis-Keever MA, Fajardo-Gutiérrez A. Epidemiología del cáncer en adolescentes. Salud Pública Mex. 2003; 45 (supl 1):s5115- s123. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000700015
Greenberg RS, Shuster JL. Epidemiology of cancer in children. Epidemiol Rev. 1985; 7:22-48.
Fajardo-Gutiérrez A, Mejía-Aranguré M, Hernández-Cruz L, Mendoza-Sánchez H, Garduño-Espinosa J, Martínez-García MC. Epidemiología descriptiva de las neoplasias malignas en niños. Rev Panam Salud Pública. 1999; 6(2):77-88. Disponible en: https://scielosp.org/pdf/rpsp/1999.v6n2/75-88/es
Fajardo-Gutiérrez A, Mejía-Aranguré M, Gómez-Delgado A, Mendoza-Sánchez H, Garduño-Espinosa J, Martínez-García MC. Epidemiología de las neoplasias malignas en niños residentes del Distrito Federal (1982-1991). Bol Med Hosp Infant Mex. 1995; 2:507-516. Disponible en: http://pesquisa.bvsalud.org/cvsp/resource/pt/lil-164449?lang=pt
Fajardo-Gutiérrez A, Mendoza-Sánchez H, Valdez-Martínez E, Mejía-Aranguré M, Yamamoto-Kimura L, Mejía-Domínguez A, et al. Frecuencia de neoplasias malignas en niños etendidos en hospitales del Distrito Federal. Estudio multicéntrico. Bol Med Hosp Infant Mex. 1996; 53:57-66.
Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social. Informe Estadístico de labores. México, D.F. IMSS;1995: p. 161.
Fajardo-Gutiérrez A. Mortalidad por cáncer en niños. Bol Med Hosp, Infant Mex. 2005; 62(1):1-3. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462005000100001
Bleyer WA. What can be learned about chilhood cancer from "Cancer Statistics Review 1973-1988". Cancer. 1993; 71(Supl):3229-3236.
Page CS, Hoffman W. Farmacología integrada neoplásica. España: Publisher Internacional: pp.501-522.
Rivera-Luna R. Conceptos generales del cáncer. En: Rivera-Luna R. Oncológica pediátrica. México: Intersistema, 2000: pp1-12.
Rivera-Luna R. El concepto del diagnóstico del cáncer. En: Diagnóstico del niño y el cáncer. España: Mosby Doyma. pp3-8.